As climate, culture, and technology evolve and become increasingly unpredictable, architecture’s stasis becomes more incongruous. Werewolf explores an emerging but under-investigated branch of ...
It’s a full moon for Werewolf Therapeutics as the company comes out of stealth with $56 million and an approach it believes can cut through the toxic effects that have limited the use of certain ...
A year after coming out of the shadows, Werewolf Therapeutics is kicking it up a notch. With $72 million in new financing, the company will push two shape-shifting cytokine drugs into the clinic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results